Showing results (31-40 of 58) with videos related to
Sort By:
Pageof 6
Journal of Surgical Oncology|March 11, 2020
Adjuvant therapy following resection of gastroenteropancreatic neuroendocrine tumors provides no recurrence or survival benefitJames R Barrett, Victoria Rendell, Courtney Pokrzywa, et al.HPB : the Official Journal of the International Hepato Pancreato Biliary Association|December 12, 2019
Tumor burden score predicts tumor recurrence of non-functional pancreatic neuroendocrine tumors after curative resectionDing-Hui Dong, Xu-Feng Zhang, Alexandra G Lopez-Aguiar, et al.Annals of Surgery|July 30, 2019
New Nodal Staging for Primary Pancreatic Neuroendocrine Tumors: A Multi-institutional and National Data AnalysisXu-Feng Zhang, Feng Xue, Ding-Hui Dong, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|October 19, 2018
Surgery Provides Long-Term Survival in Patients with Metastatic Neuroendocrine Tumors Undergoing Resection for Non-Hormonal SymptomsJeffery Chakedis, Eliza W Beal, Alexandra G Lopez-Aguiar, et al.Journal of Surgical Oncology|February 16, 2018
Nomogram predicting the risk of recurrence after curative-intent resection of primary non-metastatic gastrointestinal neuroendocrine tumors: An analysis of the U.S. Neuroendocrine Tumor Study GroupKatiuscha Merath, Fabio Bagante, Eliza W Beal, et al.Annals of Surgical Oncology|November 26, 2022
Calcifications and Cystic Morphology on Preoperative Imaging Predict Survival After Resection of Pancreatic Neuroendocrine TumorsEleftherios A Makris, John G Douglas Cannon, Jeffrey A Norton, et al.Annals of Surgery|July 9, 2019
A Novel Validated Recurrence Risk Score to Guide a Pragmatic Surveillance Strategy After Resection of Pancreatic Neuroendocrine Tumors: An International Study of 1006 PatientsMohammad Y Zaidi, Alexandra G Lopez-Aguiar, Jeffrey M Switchenko, et al.Surgery|October 4, 2018
Margin status and long-term prognosis of primary pancreatic neuroendocrine tumor after curative resection: Results from the US Neuroendocrine Tumor Study GroupXu-Feng Zhang, Zheng Wu, Jordan Cloyd, et al.The American Surgeon|January 8, 2020
Evaluating the ACS-NSQIP Risk Calculator in Primary GI Neuroendocrine Tumor: Results from the United States Neuroendocrine Tumor Study GroupEmily A Armstrong, Eliza W Beal, Alexandra G Lopez-Aguiar, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|April 4, 2019
Evaluating the ACS NSQIP Risk Calculator in Primary Pancreatic Neuroendocrine Tumor: Results from the US Neuroendocrine Tumor Study GroupApeksha Dave, Eliza W Beal, Alexandra G Lopez-Aguiar, et al.Pageof 6